Riskpilot← Back to searchSign inGet full accessBÅTSFJORD LABORATORIUM AS
ASActiveOrg 977515033Hindberggata 30, 9990 BåtsfjordTechnical testing and analysis · NACE 7120Est. 19976 employeeswww.balab.no
Revenue 2024
NOK 6,9M
+4% vs 2023
EBITDA margin
3.2%
-53% vs 2023
Equity ratio
63.9%
Financial strength
Net profit 2024
NOK 74K
-72% vs 2023
| Revenue | NOK 6,9M | +4% |
| EBITDA | NOK 219K | -53% |
| Net profit | NOK 74K | -72% |
| Total assets | NOK 2,4M | -9% |
| Equity | NOK 1,5M | +5% |
| Employees | 6 | — |
Legal name
BÅTSFJORD LABORATORIUM AS
Org number
977515033
Legal form
Aksjeselskap
NACE code
7120 · Technical testing and analysis
Founded
7. mars 1997
Share capital
NOK 200 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Hindberggata 30, 9990 Båtsfjord
Phone
+4778984540
Email
post@balab.no
Website
www.balab.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 707 | 5 350 | 5 074 | 6 604 | 6 889 |
| Staff expenses | −1 775 | −2 264 | −2 241 | −2 571 | −2 784 |
| EBITDA | 223 | 277 | 284 | 463 | 219 |
| Depreciation & amort. | −95 | −105 | −123 | −124 | −129 |
| EBIT | 128 | 172 | 161 | 339 | 90 |
| Net financials | −12 | −5 | −10 | 2 | 9 |
| Profit before tax | 116 | 167 | 151 | 341 | 100 |
| Tax | 27 | 39 | 34 | 76 | 26 |
| Net profit | 89 | 128 | 117 | 265 | 74 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 072 | 1 867 | 2 211 | 2 634 | 2 404 |
| Equity | 953 | 1 080 | 1 197 | 1 462 | 1 536 |
| Long-term debt | 127 | 90 | 82 | 60 | 30 |
| Short-term debt | 992 | 697 | 932 | 1 112 | 839 |
| Total debt | 1 119 | 787 | 1 014 | 1 172 | 868 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
63.9%
This company
38.2%
Market median
+67% vs market
20202024
Return on equity
4.8%
This company
18.4%
Market median
-74% vs market
20202024
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20202024
Asset turnover
2.87×
This company
1.12×
Market median
+156% vs market
20202024
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MT Chief Executive Officer | Chief Executive Officer | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.5% | 33.5% | 2023 | |
| Company | 33.5% | 33.5% | 2023 | |
| Company | 33% | 33% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kverva Industrier As
BÅTSFJORD LABORATORIUM AS Board members of BÅTSFJORD LABORATORIUM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mattis-Andreas Tangeraas | Chief Executive Officer | 0 companies |
| Arnfred Eilertsen | Chairman | 0 companies |
| Line Leistad | Board of Directors | 0 companies |
| Bjørn Ove Eriksen | Board of Directors | 0 companies |
| Siw Andreassen | Board of Directors | 0 companies |